廠商介紹
HOME  keyboard_arrow_right  廠商介紹  keyboard_arrow_right  生物材料  keyboard_arrow_right  AllCells
AllCells
AllCells為 Discovery Life Sciences 子公司,是採購和客製化人源血液組織和服務的行業領導者。AllCells從戰略位置的設施中收集材料,並在鄰近的實驗室中處理材料。我們提供高品質的GMP和RUO產品和服務,幫助全球生命科學研究人員和生物製造組織開發免疫療法、疫苗以及細胞和基因治療起始材料。AllCells在提供GMP產品方面擁有超過5年的專業知識。我們的設施已通過FDA註冊、IRB批准、符合AABB標準並遵守GMP指南。憑藉我們在臨床級收集方面的經驗,我們開發了一種行之有效的方法來提供最高水準的品質和合規性。
健康人類免疫細胞供應
  • 健康人類免疫細胞供應
  • 國際期刊文獻

Cryopreserved 

Leukopak

(GMP)

Cryopreserved 

Leukopak

(RUO)

PBMCs(MNCs) NK (Natural Killer) Cells T Cells
B Cells Monocytes CD34+ HSPCs Cord Blood Bone Marrow

       
Mobilized Leukopak
       

AllCells細胞採集均經IRB核准,RUO細胞能作為論文發表及臨床試驗前使用之材料,迄今已有上千篇國際期刊文獻註明細胞源自此原廠,以下為近幾年發表於高點數期刊 (5-year impact factor>10) 之代表性文章:

 

發表日期

期刊

論文名稱

使用之細胞種類

2024/1/12

Cancer Discovery

AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer

T cells

2024/1/11

Nature Biotechnology

In vivo human T cell engineering with enveloped delivery vehicles

Cryo PBMCs,

CD34+ cell

2023/11/30

Nature Biomedical Engineering

High-dimensional multi-pass flow cytometry via spectrally encoded cellular barcoding

Cryo PBMCs

2023/11/13

Nature Medicine

IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial

PBMCs

2023/10/12

Cell

Mitigation of chromosome loss in clinical CRISPRCas9-engineered T cells

PBMCs

2023/8/16

Advanced Science

Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis

PBMCs

2023/8/3

Nature Biotechnology

Systematic benchmarking of single-cell ATAC-sequencing protocols

Cryo PBMCs

2023/7/5

Cancer Immunology Research

CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function

Cryo PBMCs

2023/3/6

Nature Biotechnology

Microfluidics-free single-cell genomics with templated emulsification

Cryo PBMCs

2022/10/26

Nature

Functional antibodies exhibit light chain coherence

PBMCs

2022/9/15

Nature Biotechnology

Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing

Cryo PBMCs

2022/9/10

Nature Communications

Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen

Leukopaks

2022/8/25

Nature Biotechnology

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails

Leukopaks

2022/7/30

Nature Communications

RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R

Leukopaks

2022/7/26

Nature Communications

T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies

PBMCs

2022/6/30

Nature Communications

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing

Cryo PBMCs, NK

2022/4/28

Nature Communications

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells

PBMCs

2022/3/17

Molecular Therapy

CD3 engagement as a new strategy for allogeneic “off-the-shelf” T cell therapy

Leukopaks

2022/3/7

Nature Cancer

An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy

PBMCs

2022/2/9

Nature Communications

Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling

CD4+ T, CD8+ T,

Treg

2021/10/21

Nature Biotechnology

Single-cell profiling of proteins and chromatin accessibility using PHAGE-ATAC

CD8+ T,

Cryo PBMCs

2021/7/12

Journal for ImmunoTherapy

of Cancer

Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies

CD3+ Pan T

2021/6/1

Cancer Research

Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models

Leukopaks

2021/4/1

Molecular Therapy

Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy

Cryo PBMCs

2021/1/4

Cancer Immunology Research

CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function

PBMCs

2020/7/3

Cellular &

Molecular Immunology

ERMAP is a B7 family-related molecule that negatively regulates T cell and macrophage responses

CD3+ Pan T

 

想看其他文獻?點擊Google學術搜尋查找更多